WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 75'7001 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 423  418  412  407  401  332  257  193 
Births
Surviving infants
Pop. less than 5 years 33  33  33  34  35  34  34  29 
Pop. less than 15 years 105  106  106  106  107  101  89  74 
Female 15-49 years 117  117  116  115  114  99  68  46 

Number of reported case

(Click for retrospective incidence data for Brunei Darussalam)
Diphtheria
Japanese encephalitis
Measles 42  12  485 
Mumps 14  19  12  33 
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Brunei Darussalam)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  96  95  99*  95 
DTP1          99*  99*  99*  96  98  99 
DTP3          99  99*  90  97  95  99  99*  89 
DTP4          96 
IPV1          99* 
HepB_BD          99*  99*  95  95  96  99* 
HepB3          99  98  99*  93  96  99*  96 
Hib3          96  99*  90  97  99 
JapEnc         
MCV1          97  96  99  91  94  99  73 
MCV2          96  92  96  93  93 
PCV1         
PCV3         
Pol3          99  99  90  99*  99  99  99*  89 
Rota1         
Rota_last         
Rubella1          97  99  91  94 
TT2plus          64  79  56  78  76  72 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Brunei Darussalam)
BCG 99  99  99  96  95  99  91  99 
DTP1 99  99  98  99  98  99  97  96 
DTP3 99  99  90  97  95  99  93  89 
HepB3 99  98  99  93  96  99  96 
HepB_BD 99  99  95  95  96  99 
Hib3 96  99  90  97  95 
MCV1 97  96  99  91  94  99  99  73 
MCV2 96  92  96  93  93  95 
PAB 95  95  95  95  95  77  40 
PCV3
Pol3 99  99  90  95  99  99  92  89 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 2, 4, 6 months; Yes
DTaPIPV 5 years; Yes
HIB 1 year; Yes
HPV 13 years (x3); and catch for female students
HepB birth; Yes
Influenza_Adult Yes and also chronic illness, pregnant women, health care workers, Haj and travellers
Influenza_Pediatric < 2 years; high risk groups
MMR 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR     Yes  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number        

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100  100  100 
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100% 100        100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    No  No  No  No   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%           100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No    No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.